A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

Phase 1 Recruiting 320 enrolled Novo Nordisk A/S

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to test how taking zenagamtide tablets with different meal/water variations affects how much zenagamtide enters the bloodstream in people who have overweight or obesity. All participants will get zenagamtide.

Timeline

Start: 2026-09-07
Primary completion: 2028-06-12
Completion: 2028-06-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zenagamtide	Unknown	—	Subcutaneous
Subject	Zenagamtide	Unknown	—	Oral

A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity

Summary

Timeline

Drugs

Indications